Testosterone Base

• Post Date:

  Jan 07,2018

• Expiry Date:

  Jul 06,2018

• Detailed Description:

  Cas No. :58-22-0 Payment Method: Western Union, Moneygram.
  Product name Testosterone Base
  Other name Testoviron; Oreton; Testex; Testoderm; Testred; Virilon; Testolent
  CAS register number 58-22-0
  EINECS 200-370-5
  Molecular formula C19H28O2
  Molecular weight 288.42
  Molecular structure
  Assay 98%
  Appearance White crystalline powder
  Usage can be used as pharmaceutical material
  
  
  2. Product description
  
  
  
  Striant and Testoderm, have patent expirations of August 23, 2019 and November 10, 2019, respectively. The National Institutes of Health states that approximately 5 million American men do not produce enough of the hormone testosterone. Axiron is a highly profitable testosterone replacement therapy, with a patent expiration of February 19, 2017. The testosterone replacement Axiron generated over $48 million dollars in profit in 2011.
  
  Coined “The Wittert Study”, after Gary Wittert who is the leader of this study, this novel study is banking on being the first of many to address the worldwide epidemic of type 2 diabetes using testosterone treatment as a preventative. The International Diabetes Federation has stated that the cost to treat type 2 diabetes worldwide now hovers at 471 billion dollars.
  

• CAS Registry Number:

  58-22-0

• Synonyms:

  ;17beta-Hydroxyandrost-4-en-3-one;testosterone-dea schedule iii;testosterone gamma-irradiated cell*culture tested;testosterone cell culture tested--dea*schedule ii;Testosterone;17-hydroxyandrost-4-en-3-one;(17beta)-17-hydroxyandrost-4-en-3-one;(8xi,9xi,14xi,17beta)-17-hydroxyandrost-4-en-3-one;Testosterone Base;

• Molecular Formula:

  C₁₉H₂₈O₂

• Molecular Weight:

  288.4244

• Molecular Structure:

  

• Hazard Symbols:

   Xn:Harmful;
  

• Risk Codes:

  R40:;
  

• Safety Description:

  S24/25:;
  

• Company:

  Wuhan Lianshangwang Technology Co.,LTD     [ China ]        

• Contact:

  tumanyu

• Tel:

  86-027-88217154

• Fax:

  86-027-88048077

• Email:

  devers@ycgmp.com